GLP-1 Receptor Agonist Market 2023 – Key Players, Growth Opportunities, Industry Growth | Novo Nordisk A/S, Sanofi SA, Eli Lilly and Company, AstraZeneca Inc., Boehringer Ingelheim International GmbHy

The Business Research Company’s GLP 1 Receptor Agonist Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The GLP 1 Receptor Agonist Global Market Report 2023 evaluates GLP 1 receptor agonist market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9631&type=smp

The global GLP-1 receptor agonist market size is expected to grow from $12.48 billion in 2022 to $13.07 billion in 2023 at a compound annual growth rate (CAGR) of 4.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The global GLP-1 receptor agonist market is expected to reach $15.54 billion in 2027 at a CAGR of 4.4%.

The GLP 1 receptor agonist market segments in the report are:

GLP-1 Receptor Agonist Market By Drug Class:
Exenatide
Liraglutide
Dulaglutide
Lixisenatide
Other Drugs

GLP-1 Receptor Agonist Market By Route Of Administration:
Parenteral
Oral

GLP-1 Receptor Agonist Market By End Users:
Hospitals
Surgical Clinics
Other Users

Top Major Players:

Novo Nordisk A/S
Sanofi SA
Eli Lilly and Company
AstraZeneca Inc.
Boehringer Ingelheim International GmbH

North America was the largest region in the GLP-1 receptor agonist market in 2022.

Get More Information On The GLP 1 Receptor Agonist Market Report:
https://www.thebusinessresearchcompany.com/report/GLP-1-receptor-agonist-global-market-report

The table of contents in TBRC’s GLP 1 receptor agonist market report includes:

1. Executive Summary
2. GLP-1 Receptor Agonist Market Characteristics
3. GLP-1 Receptor Agonist Market Trends And Strategies
4. GLP-1 Receptor Agonist Market – Macro Economic Scenario
5. GLP-1 Receptor Agonist Market Size And Growth
……
26. Africa GLP-1 Receptor Agonist Market
27. GLP-1 Receptor Agonist Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The GLP-1 Receptor Agonist Market
29. GLP-1 Receptor Agonist Market Future Outlook and Potential Analysis
30. Appendix

List Of Tables

Table 1: Global Historic Market Growth, 2017-2022, $ Billion

Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion

Table 3: Global GLP-1 Receptor Agonist Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

Table 4: Global GLP-1 Receptor Agonist Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

Table 5: Global GLP-1 Receptor Agonist Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

……

Table 46: Novo Nordisk A/S Financial Performance

Table 47: Sanofi SA Financial Performance

Table 48: Eli Lilly and Company Financial Performance

Table 49: AstraZeneca Inc. Financial Performance

Table 50: Boehringer Ingelheim International GmbH Financial Performance

Read Related Reports:

Blood And Blood Components Global Market Report 2023

Blood Cancer Drugs Global Market Report 2023

Blood Group Typing Market Global Market Report 2023

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Here Are Our Recent Blog Articles:

https://healthcareresearchreports.com/influenza-diagnostic-market/

https://healthcareresearchreports.com/respiratory-devices-and-equipment-market/

Contact Us:
The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany